Ligand Pharmaceuticals Inc. (LGND)

Lifshitz & Miller announces investigation on behalf of LGND investors concerning whether LGND adequately disclosed certain deferred tax assets and outstanding convertible senior unsecured notes.

If you are an LGND investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

CONTACT US

1190 Broadway

Hewlett, NY 11557

Office: (516) 493-9780

Fax: (516) 280-7376

 

​​​​© 2021 by Lifshitz Law Firm, P.C. All rights reserved. | Sitemap | Disclaimer | Proudly created with Wix.com

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey LinkedIn Icon